Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss.

Obesity is a major risk factor for hypertension, coronary artery disease and type 2 diabetes. Weight loss is associated with significant metabolic benefits. Our objective was to examine changes in adipocytokines and interleukin (IL) 10 in obese subjects before and after weight loss. We measured anthropometric parameters, adipocytokine and IL-10 in 78 obese people who had visited obesity clinics at five university hospitals (Ajou, Ulsan, Catholic, Hanyang and Yonsei) in Korea. They restricted their caloric intake to less than their usual intake (by 500 kcal), were administered sibutramine and were given a program of exercise for 12 weeks. After 12 weeks, weight, body mass index, waist circumference, hip circumference, waist-to-hip ratio, total body fat, total cholesterol, triglyceride, tumor necrosis factor alpha (TNF-alpha), IL-6, resistin and leptin had significantly decreased, while adiponectin and IL-10 had significantly increased. A bivariate correlation analysis found that increment in IL-10 and baseline IL-10 levels significantly correlated with decrement in TNF-alpha (P<.01) and baseline adiponectin (r=.52, P<.001), respectively. These results were confirmed in a multiple regression analysis. The results suggest that weight loss after caloric restriction and medical treatment in obesity can improve metabolic risk factors through changes in some cytokines.

[1]  P. Scherer,et al.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0580 Minireview: The Adipocyte—At the Crossroads of Energy Homeostasis, Inflammation, and Atherosclerosis , 2022 .

[2]  D. Heistad,et al.  Interleukin-10 protects nitric oxide-dependent relaxation during diabetes: role of superoxide. , 2002, Diabetes.

[3]  M. Fishbein,et al.  Overexpression of Interleukin-10 by Activated T Lymphocytes Inhibits Atherosclerosis in LDL Receptor–Deficient Mice by Altering Lymphocyte and Macrophage Phenotypes , 2002, Circulation research.

[4]  V. Giusti,et al.  Adipose tissue is a regulated source of interleukin-10. , 2005, Cytokine.

[5]  Michael Motro,et al.  Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof , 2003, Cardiovascular diabetology.

[6]  F. Santilli,et al.  Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. , 2005, The Journal of clinical endocrinology and metabolism.

[7]  W. Sheu,et al.  Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[8]  Y. Nimura,et al.  Endogenous interleukin 10 prevents apoptosis in macrophages during Salmonella infection. , 1995, Biochemical and biophysical research communications.

[9]  E. Minar,et al.  Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[10]  Peng Wang,et al.  Interleukin (IL)-10 Inhibits Nuclear Factor B (NFB) Activation in Human Monocytes , 1995, The Journal of Biological Chemistry.

[11]  S. Kihara,et al.  Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. , 2000, Blood.

[12]  A. Siegbahn,et al.  IL‐10 inhibits LPS‐induced human monocyte tissue factor expression in whole blood , 1998, British journal of haematology.

[13]  J. Dayer,et al.  IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. , 1995, The Journal of clinical investigation.

[14]  A. Tedgui,et al.  Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[15]  K. Fujioka,et al.  Effects of Sibutramine Treatment in Obese Adolescents , 2006, Annals of Internal Medicine.

[16]  R. Marfella,et al.  Association of low interleukin-10 levels with the metabolic syndrome in obese women. , 2003, The Journal of clinical endocrinology and metabolism.

[17]  N. Ugochukwu,et al.  Caloric restriction inhibits up-regulation of inflammatory cytokines and TNF-alpha, and activates IL-10 and haptoglobin in the plasma of streptozotocin-induced diabetic rats. , 2007, The Journal of nutritional biochemistry.

[18]  C. Heeschen,et al.  Serum Level of the Antiinflammatory Cytokine Interleukin-10 Is an Important Prognostic Determinant in Patients With Acute Coronary Syndromes , 2003, Circulation.

[19]  H. Tilg,et al.  Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. , 2004, Biochemical and biophysical research communications.

[20]  D. Margolis,et al.  Chlamydiapneumoniae Inhibits Apoptosis in Human Peripheral Blood Mononuclear Cells Through Induction of IL-101 , 2000, The Journal of Immunology.